Norwegian study links mRNA COVID vaccines to heightened heart risks in teens

04/06/2026 / By Belle Carter

Teens receiving two mRNA COVID-19 vaccine doses faced dramatically increased risks of the following: heart inflammation (myocarditis/pericarditis) – 5x higher after the second dose; 37x spike in 12-15-year-olds (though small sample size), anaphylactic reactions – 10x higher post-second dose, epilepsy and convulsions – 65% increased risk in infection-free teens; and acute appendicitis – 47% higher risk nearly two months after vaccination.
Researchers used narrow risk windows (14-56 days), likely missing long-term complications. Independent experts warn: 25%-30% of myocarditis patients suffer lasting heart damage and 60% of young myocarditis cases still showed abnormalities 6 months post-vaccination (per FDA-funded Lancet study).
Some study authors had financial ties to Big Pharma (AstraZeneca, GSK), raising bias concerns. Critics accuse researchers of downplaying risks, burying critical data (e.g., post-window myocarditis cases).
Physicians argue mRNA vaccines “cause myocarditis in adolescents” and should not remain on the market given teens’ minimal risk from severe COVID-19. There are calls for transparency, long-term safety studies and honesty about vaccine harms.
Findings reinforce the need for: alternative health strategies (natural immunity, detox, holistic approaches). Independent risk-benefit analysis—especially since serious COVID complications were extremely rare in vaccinated teens.

A new peer-reviewed study from Norway has found that teenagers who received two doses of mRNA Wuhan coronavirus (COVID-19) vaccines faced significantly higher risks of heart inflammation, anaphylactic reactions and other adverse events compared to their unvaccinated peers.

Published in Scientific Reports, the research analyzed health data from nearly 500,000 Norwegian adolescents, raising urgent questions about vaccine safety for younger populations. Experts warn that these findings underscore the need for greater transparency, long-term safety studies and alternative approaches to public health.

Key findings: Elevated risks after vaccination

The study, conducted by researchers from the Norwegian Institute of Public Health, examined medical records of 496,432 adolescents aged 12-19, comparing vaccinated and unvaccinated individuals. Among the most alarming results:

A fivefold increase in myocarditis and pericarditis after the second dose.
37-fold spike in myocarditis cases among 12- to 15-year-olds—though based on a small sample size.
Tenfold higher rate of anaphylactic reactions post-second dose.
65% increased risk of epilepsy and convulsions in infection-free teens.
47% higher likelihood of acute appendicitis nearly two months after vaccination.

According to BrightU.AI‘s Enoch, myocarditis is inflammation of the heart muscle, while pericarditis is inflammation of the membrane surrounding the heart—both can be serious, particularly in physically active individuals and have been linked to sudden cardiac events.

Dr. Clayton J. Baker, an internal medicine physician, told the Epoch Times that the findings confirm mRNA vaccines “cause myocarditis in adolescents” and that the second dose “dramatically increases toxicity.”

Experts challenge study’s limitations

While the researchers concluded that the vaccines demonstrated overall safety, independent scientists criticized the study’s narrow risk windows—ranging from 14 to 56 days—arguing they likely undercounted long-term complications.

Brian Hooker, Chief Scientific Officer of Children’s Health Defense, warned that myocarditis cases “significantly increase long-term mortality,” with 25%-30% of patients suffering lasting damage. A separate Lancet study funded by the Food and Drug Administration (FDA) found that 60% of young myocarditis patients still showed heart abnormalities six months post-vaccination.

Steve Kirsch, founder of the Vaccine Safety Research Foundation, accused the researchers of “deliberate narrative control,” noting that critical findings—such as post-window myocarditis cases—were buried in the data. “They know most readers never look past the first page,” he said.

Conflicts of interest and calls for accountability

Several study authors disclosed financial ties to pharmaceutical giants, including AstraZeneca and GSK, prompting concerns about bias. Critics argue that the study’s framing downplayed risks while emphasizing rare adverse events as statistically insignificant.

“The evidence is indisputable—these shots cause myocarditis in young people at unacceptable rates,” said Baker. “Given the minimal risk of severe COVID-19 in adolescents, these products should not remain on the market.”

The Norwegian study adds to growing evidence that mRNA COVID-19 vaccines carry disproportionate risks for teenagers, particularly after multiple doses. As governments and health agencies weigh booster recommendations, experts demand rigorous, long-term safety reviews—and honesty about potential harms. For families navigating vaccination decisions, the findings reinforce the importance of informed consent, natural immunity and alternative health strategies in an era of escalating medical skepticism.

Watch the video below that talks about underreported myocarditis as a COVID-19 vaccine injury.

This video is from the Galactic Storm channel on Brighteon.com.